Protara Therapeutics (TARA) Institutional Ownership → Are You Positioned For The New Energy Goldrush? (From Wealthpin Pro) (Ad) Free TARA Stock Alerts $2.81 -0.09 (-3.10%) (As of 05/31/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Protara Therapeutics (NASDAQ:TARA)CurrentInstitutional OwnershipPercentage38.13%Number ofInstitutional Buyers(last 12 months)4TotalInstitutional Inflows(last 12 months)$410.54KNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$22.08K Skip Chart & View Institutional Buying and Selling Data TARA Institutional Buying and Selling by Quarter Ad Daily Strike Alliance🚀 Tap into this explosive trade opportunity asapI learned about these explosive stocks during my two decades on Wall Street… And used them to help grow my old hedge fund from just a few million to over $700 million dollars*. So it’s safe to say… these bad boys work. What’s the secret behind these special trades? Well, right now, I’m going public with the unique strategy behind these “Calendar Stocks”…Go here to see how you can exploit my next “Calendar Stock”. Protara Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/17/2024 Ikarian Capital LLC202,701$813K0.1%+7.4%0.984% 5/7/2024 Oppenheimer & Co. Inc.10,000$40K0.0%N/A0.087% 11/6/2023 Assenagon Asset Management S.A.15,831$26K0.0%-45.5%0.140% 7/26/2023 Privium Fund Management B.V.119,730$272K0.1%N/A1.059% 7/25/2023 Assenagon Asset Management S.A.29,051$69K0.0%+67.6%0.257% 2/10/2023 Opaleye Management Inc.2,692,594$7.22M2.5%-0.6%23.892% Exposed: 10 CENT Crypto to Explode May 20th? (Ad)Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 different coins that have returned over 100%... Today, he is now making the biggest crypto call of his ENTIRE career…Click For My #1 FREE Crypto for 20242/9/2023 Privium Fund Management UK Ltd119,730$321K0.2%+242.1%1.062% 1/12/2023 Assenagon Asset Management S.A.17,336$46K0.0%-70.3%0.154% 11/14/2022 Boothbay Fund Management LLC18,864$56K0.0%-26.5%0.167% 11/1/2022 Privium Fund Management UK Ltd35,000$104K0.1%N/A0.311% 8/15/2022 Opaleye Management Inc.2,684,167$8.89M4.0%+0.4%23.823% 8/12/2022 Ikarian Capital LLC257,853$756K0.1%-13.0%2.292% 8/12/2022 DLD Asset Management LP157,349$461K0.0%-31.4%1.396% 7/27/2022 Assenagon Asset Management S.A.58,389$171K0.0%+33.5%0.519% 4/25/2022 Assenagon Asset Management S.A.43,741$224K0.0%N/A0.389% 2/22/2022 DLD Asset Management LP229,231$1.55M0.1%N/A2.040% 2/15/2022 Sender Co & Partners Inc.28,502$192K0.1%N/A0.254% 2/15/2022 DLD Asset Management LP229,231$1.55M0.1%N/A2.040% 2/14/2022 Opaleye Management Inc.2,650,000$18.00M3.8%+3.6%23.585% 2/10/2022 Acadian Asset Management LLC17,219$115K0.0%N/A0.153% 11/16/2021 Two Sigma Advisers LP168,818$1.17M0.0%+189.5%1.502% 11/16/2021 Two Sigma Investments LP130,935$906K0.0%+136.3%1.165% 11/15/2021 Marshall Wace LLP15,190$105K0.0%-13.0%0.135% 11/12/2021 Trexquant Investment LP12,454$86K0.0%N/A0.111% 11/12/2021 Renaissance Technologies LLC115,900$802K0.0%+125.4%1.032% 11/12/2021 Jump Financial LLC14,500$100K0.0%N/A0.129% 11/10/2021 Goldman Sachs Group Inc.155,973$1.08M0.0%+17.9%1.388% 11/9/2021 BlackRock Inc.44,036$306K0.0%+9.7%0.392% 8/25/2021 Marshall Wace LLP17,469$170K0.0%-58.5%0.155% 8/18/2021 Ikarian Capital LLC584,804$5.70M0.5%-10.0%5.205% 8/17/2021 Millennium Management LLC129,380$1.26M0.0%+115.2%1.151% 8/16/2021 State Street Corp10,359$101K0.0%-82.8%0.092% 8/16/2021 Goldman Sachs Group Inc.132,257$1.29M0.0%N/A1.177% 8/16/2021 Marshall Wace LLP17,469$170K0.0%-58.5%0.155% 8/13/2021 Renaissance Technologies LLC51,427$501K0.0%+63.8%0.458% 8/13/2021 Northern Trust Corp22,279$217K0.0%-60.7%0.198% 8/13/2021Knott David M36,164$352K0.1%+151.7%0.322% 8/13/2021 Geode Capital Management LLC82,985$808K0.0%-25.3%0.739% 8/13/2021 Vanguard Group Inc.437,108$4.26M0.0%-4.3%3.890% 8/12/2021Ergoteles LLC17,700$172K0.0%N/A0.158% RE: Your account status (Ad)Your $200 MarketBeat account credit expires in less than twelve hours. Upgrade to MarketBeat All Access today and save $200 on your 2024-2025 MarketBeat premium subscription.Claim My Discount8/11/2021 Bank of New York Mellon Corp17,907$174K0.0%-30.3%0.159% 8/11/2021Susquehanna International Group LLP20,609$201K0.0%N/A0.184% 6/10/2021 Perceptive Advisors LLC421,642$6.64M0.1%-30.7%3.755% 5/18/2021 Millennium Management LLC60,134$947K0.0%+8.8%0.536% 5/18/2021 Alyeska Investment Group L.P.109,405$1.72M0.0%+47.0%0.974% 5/18/2021 Citadel Advisors LLC241,514$3.80M0.0%N/A2.151% 5/17/2021 Schonfeld Strategic Advisors LLC23,455$371K0.0%N/A0.209% 5/17/2021 Perceptive Advisors LLC421,642$6.64M0.1%-30.7%3.755% 5/17/2021 Rock Springs Capital Management LP689,942$10.86M0.2%+7.3%6.144% 5/17/2021 Price T Rowe Associates Inc. MD319,326$5.03M0.0%-26.4%2.844% 5/17/2021 Nuveen Asset Management LLC13,940$219K0.0%-43.4%0.124% 5/13/2021 Renaissance Technologies LLC31,400$494K0.0%+83.5%0.280% 5/13/2021 Bank of Montreal Can61,742$954K0.0%+9,988.6%0.550% 5/12/2021 Northern Trust Corp56,676$892K0.0%-10.3%0.505% 5/12/2021 Geode Capital Management LLC111,062$1.75M0.0%+5.9%0.989% 5/12/2021 Panagora Asset Management Inc.5,921$93K0.0%N/A0.053% 5/11/2021 Artisan Partners Limited Partnership379,946$5.98M0.0%+0.9%3.384% 5/7/2021 BlackRock Inc.189,876$2.99M0.0%+4.4%1.691% 2/24/2021 Alyeska Investment Group L.P.74,405$1.80M0.0%-62.8%0.664% 2/16/2021 Tri Locum Partners LP39,225$950K0.3%N/A0.350% 2/16/2021 Alyeska Investment Group L.P.74,405$1.80M0.0%-62.8%0.664% 2/16/2021 Nuveen Asset Management LLC24,647$597K0.0%N/A0.220% 2/16/2021 Price T Rowe Associates Inc. MD433,598$10.50M0.0%-3.2%3.867% 2/16/2021 Charles Schwab Investment Management Inc.12,060$292K0.0%N/A0.108% 2/13/2021 American International Group Inc.2,249$54K0.0%+86.5%0.020% 2/12/2021 Ikarian Capital LLC649,542$15.73M0.7%-10.1%5.793% 2/11/2021 Northern Trust Corp63,212$1.53M0.0%+71.3%0.564% 2/10/2021 Renaissance Technologies LLC17,110$414K0.0%-54.7%0.153% 2/10/2021 Artisan Partners Limited Partnership376,733$9.12M0.0%+27.1%3.360% 2/9/2021 Wells Fargo & Company MN13,110$317K0.0%-20.8%0.117% 2/9/2021 Bank of New York Mellon Corp25,142$608K0.0%N/A0.224% 2/5/2021 BlackRock Inc.181,888$4.40M0.0%+97.2%1.622% 12/30/2020 Deerfield Management Company L.P. Series C782,670$13.17M0.3%+80.9%6.981% 11/16/2020 Perceptive Advisors LLC608,544$10.24M0.1%N/A10.388% 11/16/2020 Boothbay Fund Management LLC64,683$1.09M0.1%+46.9%1.104% 11/10/2020 State Street Corp23,018$387K0.0%+26.8%0.393% 11/10/2020 TD Asset Management Inc.25,185$424K0.0%N/A0.430% 11/5/2020 Wells Fargo & Company MN16,563$279K0.0%+89.0%0.283% 11/3/2020 Cowen AND Company LLC124,171$2.09M0.3%N/A2.120% 8/14/2020 Bank of America Corp DE3,536$104K0.0%-56.2%0.060% 8/14/2020 Ikarian Capital LLC527,964$15.48M1.2%+17.1%9.013% 8/12/2020 American International Group Inc.1,233$36K0.0%N/A0.021% 8/12/2020Knott David M3,835$112K0.1%+45.5%0.065% 8/7/2020 New York State Common Retirement Fund3,200$94K0.0%N/A0.055% 5/18/2020 Perceptive Advisors LLC8,543$184K0.0%N/A0.146% 5/15/2020 Perceptive Advisors LLC8,543$184K0.0%N/A0.146% 5/15/2020 Ikarian Capital LLC450,772$10.37M0.8%N/A7.715% 5/13/2020 DRW Securities LLC133,543$3.07M0.1%N/A2.286% 5/12/2020 Citigroup Inc.1,813$43K0.0%N/A0.031% (Data available from 1/1/2016 forward) TARA Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of TARA shares? During the previous two years, the following institutional investors and hedge funds held shares of Protara Therapeutics shares: Opaleye Management Inc. ($7.22M), Ikarian Capital LLC ($813K), DLD Asset Management LP ($461K), Privium Fund Management UK Ltd ($321K), Privium Fund Management B.V. ($272K), Boothbay Fund Management LLC ($56K), and Oppenheimer & Co. Inc. ($40K).Learn more on TARA's institutional investors. What percentage of Protara Therapeutics stock is owned by institutional investors? 38.13% of Protara Therapeutics stock is owned by institutional investors. Learn more on TARA's institutional investor holdings. Which institutional investors have been buying Protara Therapeutics stock? The following institutional investors have purchased Protara Therapeutics stock in the last 24 months: Privium Fund Management B.V. ($119.73K), Privium Fund Management UK Ltd ($119.73K), Assenagon Asset Management S.A. ($26.36K), Ikarian Capital LLC ($14.04K), Opaleye Management Inc. ($10.14K), and Oppenheimer & Co. Inc. ($10K). How much institutional buying is happening at Protara Therapeutics? Institutional investors have bought a total of 299,996 shares in the last 24 months. This purchase volume represents approximately $813.84K in transactions. Which Protara Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Protara Therapeutics stock in the last 24 months: DLD Asset Management LP ($72.18K), Assenagon Asset Management S.A. ($54.27K), Ikarian Capital LLC ($38.57K), Opaleye Management Inc. ($15.47K), and Boothbay Fund Management LLC ($6.80K). How much institutional selling is happening at Protara Therapeutics? Institutional investors have sold a total of 187,303 shares in the last 24 months. This volume of shares sold represents approximately $518.21K in transactions. Related Companies: CSBR Major Shareholders BCLI Major Shareholders IVVD Major Shareholders GNFT Major Shareholders CHRS Major Shareholders CGEN Major Shareholders GLUE Major Shareholders ELEV Major Shareholders SCLX Major Shareholders ABOS Major Shareholders This page (NASDAQ:TARA) was last updated on 5/31/2024 by MarketBeat.com Staff From Our PartnersDems have chosen Biden replacement?Paradigm PressShocking $16T Elon Musk Crypto LeakCrypto 101 MediaThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarWho are Nvidia’s New Silent Partners?Weiss RatingsMissed NVDA? Buy this AI stock NOWChaikin Analytics41 banks launch ‘crypto dollar’Stansberry ResearchDo This Before July 30 2024 To Claim Trump’s Gift Wealthpin ProA once-in-a-century profit opportunity?Digital Mavericks Media Adding Choose a watchlist: Watchlist My Default Watchlist Adding Protara Therapeutics, Inc. You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.